Cargando…
The Key Role of GM1 Ganglioside in Parkinson’s Disease
We have endeavored in this review to summarize our findings, which point to a systemic deficiency of ganglioside GM1 in Parkinson’s disease (PD) tissues. These include neuronal tissues well known to be involved in PD, such as substantia nigra of the brain and those of the peripheral nervous system,...
Autores principales: | Chowdhury, Suman, Ledeen, Robert |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8961665/ https://www.ncbi.nlm.nih.gov/pubmed/35204675 http://dx.doi.org/10.3390/biom12020173 |
Ejemplares similares
-
Systemic deficiency of GM1 ganglioside in Parkinson’s disease tissues and its relation to the disease etiology
por: Ledeen, Robert, et al.
Publicado: (2022) -
Age-Related Decline in Gangliosides GM1 and GD1a in Non-CNS Tissues of Normal Mice: Implications for Peripheral Symptoms of Parkinson’s Disease
por: Chowdhury, Suman, et al.
Publicado: (2023) -
Subnormal GM1 in PBMCs: Promise for Early Diagnosis of Parkinson’s Disease?
por: Alselehdar, Samar K., et al.
Publicado: (2021) -
The relationship between depletion of brain GM1 ganglioside and Parkinson's disease
por: Sonnino, Sandro
Publicado: (2023) -
Pathophysiology of Ganglioside GM1 in Ischemic Stroke: Ganglioside GM1: A Critical Review
por: Zhang, Wenchao, et al.
Publicado: (2019)